Real-time enrollment status for this chronic lymphocytic leukemia (cll) clinical trial
Current Status
Recruiting
Checked: August 29, 2026 at 5:32 PM UTC
| NCT Number | NCT07024706 |
| Recruiting Status | Recruiting |
| Condition | Chronic Lymphocytic Leukemia (CLL) |
| Phase | PHASE2 |
| Target Enrollment | 80 participants |
| Active Locations | 5 sites in the US |
| Sponsor | AstraZeneca |
| Last Updated on CT.gov | August 6, 2026 (3 weeks ago) |
As of August 29, 2026: Clinical trial NCT07024706 is currently recruiting participants. This phase2 study for chronic lymphocytic leukemia (cll) is actively seeking new participants at 5 locations across the United States. The study is sponsored by AstraZeneca. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07024706 is actively recruiting participants as of August 29, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 5 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07024706 was last updated 3 weeks ago (August 6, 2026). HelloStudys verifies this status automatically.